Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma

This study has been completed.
Information provided by (Responsible Party):
Washington University School of Medicine Identifier:
First received: December 4, 2008
Last updated: March 9, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)